NATCO Pharma Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of NATCO Pharma Limited generated cash of $12,116,000,000, which is more than the previous year. Cash used in financing activities reached the amount of -$2,469,000,000 last year. Net change in cash is therefore -$615,000,000.
Cash Flow
| 2010 | 773.69M | -608.49M | -341.44M |
|---|---|---|---|
| 2011 | 675.97M | -1.19B | 771.02M |
| 2012 | 649.40M | -1.26B | 627.75M |
| 2016 | 1.02B | -1.75B | 856.13M |
| 2018 | 4.63B | -11.15B | 6.50B |
| 2020 | 4.17B | -1.67B | -2.50B |
| 2021 | 2.98B | -1.03B | -1.85B |
| 2023 | 8.49B | -4.77B | -3.63B |
| 2024 | 12.11B | -10.32B | -2.46B |
NATCOPHARM.NS Cash Flow Statement (2010 – 2023)
| 2023 | 2022 | 2020 | 2019 | 2017 | 2015 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 1.31B | 1.11B | 198M | 283M | 235M | 124.41M | 316.96M | 69.45M | 273.85M |
Operating activities | |||||||||
Net income | 13.88B | 8.61B | 5.79B | 5.68B | 8.87B | 2.06B | 596.08M | 535.11M | 487.18M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||||
Depreciation and amortization | 1.86B | 1.63B | 1.16B | 998M | 662M | 509.52M | 159.07M | 158.81M | 211.50M |
Stock-based compensation expense | 0 | 0 | 126M | 144M | 180M | 96.86M | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 0 | 126M | 144M | 180M | 96.86M | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | |||||||||
Accounts receivable, net | -3.41B | -2.22B | 1.25B | -593M | -1.75B | -788M | 0 | 0 | 0 |
Inventories | 424M | 191M | -2.40B | -289M | -895M | -1.38B | -85.32M | -250.22M | -28.22M |
Accounts payable | -281M | 1.02B | -1.09B | 417M | 64M | 1.50B | 0 | 0 | 0 |
Cash generated by operating activities | 12.11B | 8.49B | 2.98B | 4.17B | 4.63B | 1.02B | 649.40M | 675.97M | 773.69M |
Investing activities | |||||||||
Purchases Of Investments | -11.85B | -5.36B | -1.84B | -2.46B | -5.69B | -208.45M | -5.35M | -23.65M | -3.07M |
Investments In Property Plant And Equipment | -3.39B | -2.05B | -2.54B | -3.58B | -4.24B | -1.57B | -1.28B | -959.42M | -374.85M |
Acquisitions Net | 0 | 201M | 1.15B | 1.06B | 185M | 23M | 0 | 0 | 0 |
Cash generated by investing activities | -10.32B | -4.77B | -1.03B | -1.67B | -11.15B | -1.75B | -1.26B | -1.19B | -608.49M |
Financing activities | |||||||||
Common Stock Issued | 0 | 0 | 1M | 475M | 8.95B | 3.34B | 675M | 0 | 1.07M |
Payments for dividends | -1.70B | -1.00B | -1.13B | -1.53B | -1.81B | -260.69M | -106.72M | -65.21M | -106.42M |
Repurchases of common stock | -2.53B | -74M | -140M | -536M | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 1.97B | -2.39B | -484M | -801M | 0 | -1.29B | -270.27M | -428.12M | -818.96M |
Cash used in financing activities | -2.46B | -3.63B | -1.85B | -2.50B | 6.50B | 856.13M | 627.75M | 771.02M | -341.44M |
Net Change In Cash | -615M | 208M | 60M | -85M | -18M | 117.24M | 29.47M | 251.65M | -204.39M |
Cash at end of period | 704M | 1.31B | 258M | 198M | 217M | 241.65M | 346.44M | 321.11M | 69.45M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |